Heart pump may boost survival in High-Risk surgery patients
NCT ID NCT05529654
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using the Impella 5.5 heart pump during and after heart surgery improves outcomes for 100 patients with severely weakened hearts. The pump supports blood flow, aiming to reduce death, stroke, kidney failure, and heart failure after surgery. Participants must be stable enough for specific heart procedures like bypass or valve repair.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
-
Baylor Scott and White - Plano
Plano, Texas, 75093, United States
-
Brigham & Women's
Boston, Massachusetts, 02115, United States
-
Cardiology Associates Research Group
Jonesboro, Arkansas, 72401, United States
-
Centennial Heart Cardiovascular
Nashville, Tennessee, 37203, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Hospital of The University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Keck School of Medicine
Los Angeles, California, 90033, United States
-
Mass General Hospital
Boston, Massachusetts, 02114, United States
-
Minneapolis Heart Institute Foundation/Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
NCH Rooney Heart Institute
Naples, Florida, 34102, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
New Hanover Regional Medical Center
Wilmington, North Carolina, 28401, United States
-
New York- Presbyterian Hospital/ Columbia University Medical Center
New York, New York, 10032, United States
-
Providence St. Vincent Medical Center
Portland, Oregon, 97225, United States
-
Tri-City Medical Center
San Diego, California, 92056, United States
-
University of Texas Austin Dell Medical School/Ascension Texas
Austin, Texas, 78705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart stem cell trial pulled before it even started
- Heart valve repair may unlock higher doses of key heart failure drugs
- AI reads your Heart's future: new test spots cancer drug danger
- AI reads your Heart's electrical signals to predict failure years in advance
- Quick heart scans at your GP could spot silent valve disease
- Heart pump may boost survival in complex stenting